1 Aug 2022 , 05:29 PM
Net Loss of Krebs Biochemicals & Industries reported to Rs 8.14 crore in the quarter ended June 2022 as against net loss of Rs 9.42 crore during the previous quarter ended June 2021. Sales rose 83.70% to Rs 9.92 crore in the quarter ended June 2022 as against Rs 5.40 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 9.92 | 5.40 | 84 |
| OPM % | -63.31 | -120.74 | – |
| PBDT | -6.45 | -8.00 | 19 |
| PBT | -8.14 | -9.42 | 14 |
| NP | -8.14 | -9.42 | 14 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
